476060.KQ
Onconic Therapeutics
KOE · Healthcare · Biotechnology · KR
KRW 12,620.00
−3.44%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 4.53x
- P/E 2027E
- 2.49x
- P/E 2028E
- —
- P/S forward
- 13.36x
Trailing multiples
Trailing twelve months
- P/E TTM
- 23.22x
- PEG TTM
- —
- Price / book
- 6.60x
- Price / sales
- 6.89x
- Price / cash flow
- 33.69x
Enterprise value
- Enterprise value
- KRW 503.9B
- EV / sales
- 6.13x
- EV / EBITDA
- 26.58x
- EV / EBIT
- 29.12x
- Market cap
- KRW 566.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026